Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders
Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders
Recruiting · NCT05962216 · Registry updated 2025-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, depressive disorder, psychiatric disorder | Recruiting | Not stated | 2025-07-08 | NCT05962216 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dr. Albert Kar-Kin Chung | 1 |
| Otsuka Pharmaceutical Co., Ltd. | 22 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Queen Mary Hospital | Hong Kong | Hong Kong | 3 |